Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:2101, doi:10.1016/j.jacc.2009.04.099
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chattopadhyay, S.
Right arrow Articles by Anderson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chattopadhyay, S.
Right arrow Articles by Anderson, R. A.

IMAGES IN CARDIOLOGY

Coronary Artery Aneurysm Formation Within New-Generation Bare-Metal Stents

Not Just Due to Drug Elution!

Sudipta Chattopadhyay, MD, Timothy Kinnaird, MD and Richard A. Anderson, MD

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom

Manuscript received March 31, 2009; accepted April 6, 2009.



Figure 1
A 57-year-old woman with chronic stable angina underwent uncomplicated stenting in the left anterior descending artery (LAD) and right coronary artery (RCA) (A) with excellent results in the target vessel. Coronary angiogram repeated for atypical chest pain 6 months later demonstrated coronary artery aneurysm (CAA) (arrowheads) within the segments stented with a bare-metal stent (BMS) in both arteries (B), confirmed on intravascular ultrasound examination (C). Arrows show the extent of the aneurysm as seen on the intravascular ultrasound images. The RCA segment stented with the everolimus-eluting stent Xience (Abbott Laboratories, Abbott Park, Illinois) was free of aneurysm. History did not suggest any predisposition to aneurysm formation, and systemic arteritis was excluded. The patient was treated conservatively with life-long dual antiplatelet therapy to avoid compromising flow in branches arising from the aneurysmal segments. She remains well currently. Repeat angiogram (D and E) shows a partial regression of the aneurysms (arrowheads).

CAA within BMS is rare at 0.2% to 1.5% in recent trials. Simultaneous CAA within 2 different (stainless steel and cobalt-chromium) thin-strut corrugated-ring design BMS implanted in separate vessels in the same patient is a novel finding. This is unreported in Multilink Vision (Abbott Laboratories) and Liberte (Boston Scientific, Natick, Massachusetts) stents.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chattopadhyay, S.
Right arrow Articles by Anderson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chattopadhyay, S.
Right arrow Articles by Anderson, R. A.

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement